SPRO Oct 2024 2.500 call
| Previous close | 0.6400 |
| Open | 0.6400 |
| Bid | 0.1000 |
| Ask | 1.1000 |
| Strike | 2.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.6400 - 0.6400 |
| Contract range | N/A |
| Volume | |
| Open interest | 66 |
GlobeNewswireSpero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that on April 29, 2024, the Compensation Committee of Spero’s Board of Directors approved the grant of an aggregate of 10,833 restricted stock unit awards (RSUs) to a new employee under the Spero Therapeutics,
Insider Monkey14 Cheap Penny Stocks to Buy According to Analysts
In this article, we will take a detailed look at the 14 Cheap Penny Stocks to Buy According to Analysts. For a quick overview of such stocks, read our article 5 Cheap Penny Stocks to Buy According to Analysts. The US stock market is going through a pullback as optimism around rate cuts fades. The AI-led rally that boosted […]
Simply Wall St.Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
It's been a good week for Spero Therapeutics, Inc. ( NASDAQ:SPRO ) shareholders, because the company has just released...
